Accretion Pharmaceuticals Limited
Accretion Pharmaceuticals Limited, established in 2012, produces and sells tablets, capsules, and healthcare products, offering both generic and branded formulations. It provides contract manufacturing services for domestic and international clients, including government and private institutions.
What Accretion files
- Others33
- Investor Meet12
- Updates8
- Important3
- Board Meeting2
- PPTs2
Accretion Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
Accretion Pharmaceuticals Limited has informed the Exchange regarding Notice of Postal Ballot
The company's board approved expanding its business scope in pharmaceuticals and healthcare. It also seeks to increase borrowing limits and enhance flexibility for loans, guarantees, and investments. These strategic moves, aimed at future growth, require shareholder approval via postal ballot.
Accretion Pharmaceuticals Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
Accretion Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 27, 2026